Hepatitis B virus infection in patient with Hodgkin's and non-Hodgkin's lymphoma and clinical significance

Basit Öğe Kaydı
dc.contributor.authorAltintaş A.
dc.contributor.authorKaplan M.A.
dc.contributor.authorÇil T.
dc.contributor.authorYilmaz Ş.
dc.contributor.authorBayan K.
dc.contributor.authorDaniş R.
dc.contributor.authorAyyildiz O.
dc.date.accessioned2024-04-24T18:43:37Z
dc.date.available2024-04-24T18:43:37Z
dc.date.issued2007
dc.departmentDicle Üniversitesien_US
dc.description.abstractHepatitis B virus (HBV) is a hepatotrophic virus that have also a potential to replicate in lymphoid cells. This has led to evaluation of potential association between HBV infection and lymphomas. In this study, we retrospectively determined the HBV surface antigen and anti-HBs antibody in Southeastern region of Turkey where the prevalence of this infection is relatively high. A total of 276 patients were recruited, 203 (73.6%) with non-Hodgkin's lymphoma (NHL) and 73 (26.4%) with Hodgkin's lymphoma (HL), in the period of January 1995 and December 2005. In total, 40 (14.5%) patients were positive for HBsAg. Of them, 12 (16.4%) were in HL group and 28 (13.7%) were in NHL group. Anti-HBs antibody was positive in total of 123 patients [29 (39.7%) in HL and 94 (46.3%) in NHL]. Eleven patients were taken lamivudine prophylaxis (100 mg po / day) in the last two years. Ten were not developed a reactivation, while one with diffuse large-cell NHL reactivated. Besides, one patients with HL who was not taking prophylaxis developed anti-HBcIgM positive with aminotransferase elevations compatible with acute hepatitis. Although HBsAg positivity was higher in lymphoma patients than in general population in our study, for a possible casual association there is need for prospective studies with wider populations. In conclusion, prophylaxis with lamivudine of HBV carriers is important and treatment should be continued until one year after termination of chemotherapy.en_US
dc.identifier.endpage6en_US
dc.identifier.issn1306-133X
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-34248140254en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://hdl.handle.net/11468/24221
dc.identifier.volume17en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofUHOD - Uluslararasi Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis B Virusen_US
dc.subjectLymphoproliferative Disordersen_US
dc.titleHepatitis B virus infection in patient with Hodgkin's and non-Hodgkin's lymphoma and clinical significanceen_US
dc.title.alternativeHodgkin ve non-Hodgkin lenfoma olgularinda hepatit B enfeksiyonu ve klinik önemien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu